Biofrontera

Biofrontera LT Debt/Equity

Long-Term Debt to Equity Ratio of Biofrontera (B8FK.DE) as of Nov 21, 2026.

LT Debt/Equity

0.00

Last updated:

Long-Term Debt to Equity Ratio of Biofrontera is 2021 0.00 . Long-Term Debt to Equity Ratio of Biofrontera was 2020 - . It decreases by % lower compared to the previous year.

The Biofrontera LT Debt/Equity history

The Biofrontera LT Debt/Equity history
YEARLT Debt/EquityYoY
0.00—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Biofrontera Stock analysis

What does Biofrontera do? Biofrontera AG generates revenue by developing, selling, and distributing dermatological drugs and medical cosmetics for skin care, protection, and treatment. The company markets its portfolio which includes Ameluz for the photodynamic therapy of actinic keratoses, the PDT lamp BF-RhodoLED used in conjunction with Ameluz treatment, and Belixos, a herbal dermatological cream for conditions such as insect bites, burns, neurodermatitis, and psoriasis. These products address the needs of patients and healthcare providers seeking treatments for skin diseases and regenerative care of damaged skin. The firm also engages in the clinical development of drug candidates to expand its future revenue streams. This includes BF-derm1, a tablet containing an inhibitor that blocks histamine synthesis to prevent allergic reactions, and BF1, a selective serotonin receptor agent aimed at preventing migraines. Through its five wholly owned subsidiaries, notably B, Biofrontera AG supports these development and distribution activities from its headquarters in Leverkusen, Nordrhein-Westfalen. Biofrontera is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Biofrontera stock

On Eulerpool you can find the complete historical development of Long-Term Debt to Equity Ratio Biofrontera since 2006 – with annual values, charts, and detailed analysis.

The LT Debt/Equity ratio measures long-term financial leverage. It shows how much permanent debt capital is used relative to equity financing.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Long-Term Debt to Equity Ratio's Biofrontera with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Leverage — Biofrontera

All Key Metrics — Biofrontera